Substance Misuse in LGBT populations

Slides:



Advertisements
Similar presentations
Injecting drug use and infections. Vivian Hope IDU Team, HIV & STI Department, Health Protection Services – Colindale Dr Vivian Hope, Dr Fortune Ncube.
Advertisements

10 year history serving the Substance Use needs of Londons LGBT ( L esbian, G ay, B isexual & T ransgender) community 8,000 contacts, 700+ people in various.
Introduction to Drug Misuse Les Goldman. Objectives Gain basic knowledge of Common current patterns of drug misuse Local referral pathways Available treatments.
What is good HIV prevention? Ross Boseley Health promotion Coordinator Terrence Higgins Trust Brighton.
Providing substance misuse support to LGB & T people New trends, challenges and developing a strategic approach through commissioning Monty Moncrieff.
CLUB DRUGS Dr Alexander Margetts, Clinical Psychologist
LGBT* Dual Diagnosis Pat, Mark, Andy. Stonewall- Gay and Bisexual Men’s Health Survey ,861 gay and bisexual male respondents from across Britain.
BAME MSM Prevention Parminder Sekhon Executive Director of Programmes.
The UK’s only LGBT Substance Misuse Service 10 year history serving the Substance Use needs of London’s LGBTQ community 8,000 contacts, 700+ people in.
Substance misuse sector Or Sexual health sector? Is this a drug problem Or A sex problem?
Chemsex: a treatment response Monty Moncrieff Chief Executive, London Friend HIV Prevention England Conference 19 th February 2015.
Introduction PRO(TECT) is a partnership project between Terrence Higgins Trust and The Claude Nicol Clinic (CNC) GUM in Brighton. It provides a new tailor-made.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Brief Interventions for HIV+ Persons Thomas L. Patterson Shirley J. Semple University of California, San Diego Research supported by NIMH RO1MH61146 &
Substance Use, Substance Choice, and Unprotected Sex among Young Asian/Pacific Islander (API) Men Who Have Sex with Men (MSM) Kyung-Hee Choi, 1 Don Operario,
Drugs Intermediate 1 Biology Unit 1 – Health and Technology.
Addressing Crystal Methamphetamine Use Among Gay and Bisexual Men: A Treatment Center’s Response Joe Ruggiero, Ph.D. –Director, Outpatient Services The.
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
Milwaukee Partnership to Respond to 2009 EPI AID Study in Milwaukee Brenda Coley Diverse and Resilient, Inc.
Annual report 2010: the state of the drugs problem in Europe.
California HIV Prevention Indicators 2 nd Edition McCandless RR 1,Truax SR 2, Aoki BK 1, Lemp GF 1, Montgomery M 2, Webb DS 2, Lees N 2 1 Universitywide.
MRCPsych seminar series Epidemiology of addictive disorders: a brief review Dr Stuart McLaren March 2010.
All Change! Infections, injecting drug use and harm reduction. Vivian Hope IDU Team, HIV & STI Department, Health Protection Services – Colindale Dr Vivian.
Injection drug use among men who have sex with men (MSM) Dr Adam Bourne Sigma Research London School of Hygiene & Tropical Medicine
The Sexual Practices of Combined Methamphetamine and Nitrate Users Michael T. Maurer, Ph.D., M.H.A.
getting the message across
Darrin Aiken – Program Coordinator Christopher Jackson – Prevention Training Specialist.
 ARC Under 18’s Substance Misuse Programme 160A Sunshine Industrial Estate Crumlin Road Crumlin Dublin 12 Presented by:Jimmy Norman.
Drugs Forensic Science. Introduction Humans have used drugs of one sort or another for thousands of years -wine was used at least from the time of the.
Jennifer R. Havens, PhD, MPH Associate Professor
PROMOTING THE HEALTH OF MEN WHO HAVE SEX WITH MEN WORLDWIDE A training curriculum for providers.
Young Person’s substance misuse service in Hampshire Julie Poling – Team Leader.
Results from the STEAM Survey Elizabeth Barash, MPH.
SECTOR Statutory – Private – Voluntary - Community DELIVERY SETTINGS & SERVICE INTERFACES INTEGRATED CARE PATHWAYS STEP WISE HEALTH PROMOTION SAFEGUARDING.
Drug-related deaths Phil Conley Health Improvement Programme Manager September 2015.
Longitudinal Trends in Multiple Drug Use Among Young Injection Drug Users Jennifer Jackson Bloom, MPH §, Stephen Lankenau, PhD ‡ §, Bill Sanders, PhD ‡
Chemsex related admissions to a city centre hospital Chris Ward 1, Annaliese Ashman 2, Terri Anderson 3, Rebecca Evans 1, Debbie Thomas 1, Orla McQuillan.
Conversation 4: Community Perspectives on Chemsex
Is on-demand PrEP a suitable tool for MSM who practice chemsex
Making changes; a Care Plan
Sex between men that occurs under the influence of Mephedrone, GHB/GBL or Crystal Meth
Public Health Forum on LGBT Health
Findings from MISI 2015 (with a focus on HIV and STI testing)
56 Dean Street, Chelsea and Westminster Hospital, London
Drug and Alcohol Use in Young People
Young people, substance misuse and PHE
Alex Parr & Carrie Llewellyn Brighton and Sussex Medical School, UK
Effective HIV & SRH Responses Among Sex Workers and other Key Populations Module 1: National Data.
A clinical perspective of Chemsex
**Funded in part by NIMH RO3MH and NCRR K12RR017707
Kristen Williams, Jonathan J.K. Stoltman, and Mark K. Greenwald
Narcotics, Stimulants, and Depressants
Making changes; a Care Plan
Cascade of care for persons newly diagnosed
The Albert Kennedy Trust – No young person should have to
Sherry Deren, Sung-Yeon Kang, Milton Mino & Honoria Guarino
Lysa Silveira Remy, BA, MSc.
Narcotics, Stimulants, and Depressants
Andy Mills Manager Complex Needs Team
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
Hepatitis B and C management pathways in prison:
Life in Scotland for LGBT Young People
Drug use among MSM (overview with focus on chemsex)
STIs among people who use drugs
Figure 1: Drug of choice, ACT,
National Confidential Inquiry into Suicide and Safety in Mental Health
A Collaborative Response Kiran Santlal & Adam Shanley
Sexually Transmitted Infections (STIs) in Ireland, 2016
PrEP in Brazil: 18 months of implementation as a public health policy
High levels of depression among Peruvian men who have sex with men and transgender women: implications for HIV prevention and treatment care Jerome T.
Presentation transcript:

Substance Misuse in LGBT populations Jamie Willis Training & Outreach Manager Antidote @ London Friend

London Friend Small charity working to promote health & well-being of lesbian, gay, bisexual and trans (LGBT) people Identity, self esteem, mental health, sexual health, well-being Drug and alcohol service – Antidote Almost exclusively club drug use

Antidote experience Established 2002 at Turning Point Moved to London Friend 2011 Community support service – psychosocial interventions, complementary therapies Mid – late 2000s increased crystal and G Medical pathways Club Drug Clinic and GUM satellites Chemcheck group SWAP - Structured Weekend Antidote Programme

What is chemsex? Most significant recent issue in LGBT drug use Intentional use of drugs to help enhance and/or facilitate sex Gay, bisexual, MSM Three main drugs: mephedrone, GHB/GBL, crystal methamphetamine

Referrals from GUM, A&E, statutory drug services Changing trends Issue 2005 – 179 clients 2013/2014 – 758 clients Alcohol 130 – 73% 79 – 11% Cocaine 46 – 26% 86 – 11% Ecstasy/MDMA 37 – 21% 9 – 1% Ketamine 23 – 13% 44 – 6% GHB/GBL 3 – 2% 334 – 46% Crystal meth 0 – 0% 373 – 51% Mephedrone 461 – 64% Heroin 5 – 3% 2 – >1% Crack 14 – 8% 6 – 1% Referrals from GUM, A&E, statutory drug services 8% 63%

Chems Mephedrone (Mcat, meow meow etc.) £15 to £20 per gram - Stimulant; a cathinone, similar to amphetamine. Used for dancing, sex Increasingly responsible for psychotic presentations Crystal Methamphetamine (Crystal, Tina, Ice) £60 -£80 per half gram - Powerful amphetamine, crystalline form (occasionally powdered) Used widely by MSM in sexual contexts. (Low incidence of non MSM use in UK) Powerful high, compulsive behaviour, increased libido, users awake for days Increasingly responsible for psychotic presentations/sexual health consequences

GBL (GHB) Class C Gammabutyrolactone/Gammahydroxybutyrate “G”, “Gina” A solvent, used industrially Liquid (ingested orally) 2 principal dangers; toxicity (overdose) and physical dependence 30ml bottle = (approx) £15 Sedative (though with stimulant-like effects) Euphoria; used to dance, sleep; for sex, confidence, as an anti-depressant Used mostly by LGB communities

G deaths Data published by Imperial in December 2016 61 G-related deaths 2011-15 Notable increase in 2015 (29 deaths, 119% rise on 2014) All but one male, age range 22 – 67 Other chemsex drugs detected in 65% of cases 33% of sample known to be HIV+ Rise “at least in part” associated to chemsex

Let’s talk technology

Chemsex data The Gay Men’s Sex Survey 2014 has some of the most up to date published data: Lifetime use of: crystal (8.3%); GHB/GBL (12.5%); mephedrone (16.5%) Injecting: ever (2.9%); ever in London (3.33%); HIV+ (11.3%); HIV+ in London (14.4%) In past year those who injected: crystal (59.9%); mephedrone (60.65); GHB/GBL (1.8%)

Recent trends in MSM 55% injecting history Prefer to use ‘bareback’ sites to find sex 39 % HIV positive 46% with HIV attribute diagnosis to drugs 40% non-adherence to ARVs whilst ‘high’ 91% of HIV negative men accessing PEP said that that this was following a chemsex session

Recent trends in HIV + MSM 1 in 3 HIV + MSM reported chemsex in the last year which was associated with risky sexual behaviour & STI diagnosis Chemsex, associated with increased odds of sexual behaviour with a risk of onwards HIV transmission (i.e. sdUAI with a detectable VL) Chemsex associated with greatly increased odds of hepatitis C infection (“Chemsex” and High-Risk Sexual Behaviours in HIV + MSM” Pufall et al, Imperial College London, PHE, UCL)

Who seeks Support ? Typically different profile to traditional drug services Higher functioning Less likely to have criminal record Respond well to interventions & treatment Triggers include arrest & negative experience whilst using

Psychosocial Intervention Intervention vs Treatment/Support – needs greater differentiation Assertive Community & Healthcare Based Interventions - Only 12% of Antidote clients would feel comfortable accessing ‘mainstream’ treatment Motivational Interviewing, CBT, relapse prevention - But with cultural adaptations: e.g. relapse prevention through management of online sexual-social profiles Tackle sexual health and drug use together

Contact details www.londonfriend.org.uk www.londonfriend.org.uk/antidote antidote@londonfriend.org.uk www.facebook.com/londonfriend Twitter: @JamieWillis71 @lgbtfriend 020 7833 1674